Indinavir/ritonavir‐based therapy in HIV‐1‐infected antiretroviral therapy‐naive patients: comparison of 800/100 mg and 400/100 mg twice daily
- 25 January 2005
- journal article
- clinical trial
- Published by Wiley in HIV Medicine
- Vol. 6 (1) , 1-6
- https://doi.org/10.1111/j.1468-1293.2005.00255.x
Abstract
SCOPUS: ar.jFLWINinfo:eu-repo/semantics/publisheKeywords
This publication has 19 references indexed in Scilit:
- Antiretroviral Concentrations in Untimed Plasma Samples Predict Therapy Outcome in a Population with Advanced DiseaseThe Journal of Infectious Diseases, 2003
- Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral loadAIDS, 2003
- Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometryJournal of Mass Spectrometry, 2003
- Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patientsAIDS, 2003
- Risk factors for indinavir-related renal colic in HIV patientsAIDS, 2002
- Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV InfectionNew England Journal of Medicine, 2002
- High Indinavir Cmin Is Associated With Higher Toxicity in Patients on Indinavir-Ritonavir 800/100 mg Twice-Daily RegimenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Therapeutic Drug Monitoring of Indinavir in HIV-Infected Patients Undergoing HAARTInfection, 2002
- Pharmacokinetic Profile and Tolerability of Indinavir-Ritonavir Combinations in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2001
- The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic responseAIDS, 1999